Triveni Bio

Triveni Bio is a biotech company developing genetics-informed precision medicines for I&I disorders.

Triveni has roped in $115 million to advance preclinical antibody treatments designed to take on immunological and inflammatory disorders.

Gabrielle Masson Oct 2, 2024 7:00am

Jun 14, 2024 8:30am